Episode
How Quantum Computing Is Redesigning Antibiotics
- Published
- Jul 17, 2026
- Duration seconds
- 584
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/quantum-computing-business-with-fexingo-hardware-software-and-enterprise-quantum-7872009/episodes/how-quantum-computing-is-redesigning-antibiotics/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/quantum-computing-business-with-fexingo-hardware-software-and-enterprise-quantum-7872009/how-quantum-computing-is-redesigning-antibiotics.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode of Quantum Computing Business with Fexingo, Lucas and Luna explore how quantum computers are being used to redesign antibiotics to fight superbugs. They focus on a specific case: Roche's collaboration with 1QBit, where quantum algorithms screened molecular configurations for a new class of antibiotics targeting gram-negative bacteria. The hosts discuss why classical computing struggles with the combinatorial chemistry of antibiotic design, how quantum annealing tackles the problem, and what early results suggest about the timeline for real-world impact. They also touch on the economics of antibiotic development and why quantum's advantage may come sooner here than in other drug discovery areas. A concrete look at one of the most promising near-term applications of quantum computing in life sciences. #QuantumComputing #Antibiotics #Superbugs #DrugDiscovery #Roche #1QBit #QuantumAnnealing #CombinatorialChemistry #GramNegativeBacteria #MolecularDesign #Pharma #LifeSciences #BusinessAndTechnology #FexingoBusiness #BusinessPodcast #TechnologyPodcast #QuantumBiology #AntimicrobialResistance Keep every episode free: buymeacoffee.com/fexingo